Domark International (DOMK) 10-Q 14 Oct 14 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Aug. 31, 2014
Document And Entity Information	'
Entity Registrant Name	'Domark International Inc.
Entity Central Index Key	'0001365160
Document Type	'10-Q
Document Period End Date	31-Aug-14
Amendment Flag	'false
Current Fiscal Year End Date	'--05-31
Is Entity a Well-known Seasoned Issuer?	'No
Is Entity a Voluntary Filer?	'No
Is Entity's Reporting Status Current?	'Yes
Entity Filer Category	'Smaller Reporting Company
Entity Common Stock, Shares Outstanding	1,760,869,080
Document Fiscal Period Focus	'Q1
Document Fiscal Year Focus	'2015

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Aug. 31, 2014	31-May-14
CURRENT ASSETS	'	'
Cash and cash equivalents	'	$460
Loan receivable from consultant	36,203	36,203
Prepaid expenses	4,500	4,500
TOTAL CURRENT ASSETS	40,703	41,163
INVESTMENTS	1,144,166	1,144,166
OTHER ASSETS	'	'
Patents, net of accumulated amortization of $6,105 and $3,605, respectively	64,397	66,897
Licenses, net of accumulated amortization of $111,758 and $60,890, respectively	198,242	249,102
TOTAL OTHER ASSETS	262,639	315,999
TOTAL ASSETS	1,447,508	1,501,328
CURRENT LIABILITIES	'	'
Bank overdraft	35	'
Note payable to bank	180,000	180,000
Accounts payable & accrued expenses	61,741	56,940
Amounts due under Licensing Agreement with Wazzamba SA	224,924	224,925
Loans payable to consultants and stockholders	167,636	188,972
Convertible notes payable (net of unamortized discounts of $742,235 and $674,886, respectively)	22,936	67,414
Derivative liability for convertible notes payable	1,941,872	1,748,982
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	2,599,144	2,467,233
STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares	50	50
Common stock, $0.001 par value, authorized 4,000,000,000 shares: 1,885,668,882 & 801,626,781 issued, 1,760,869,080 and 676,806,979 shares outstanding as August 31, 2014 & May 31, 2014 respectively	1,885,668	801,627
Less: Treasury Stock ( 124,819,820 shares ) as of August 31 & May 31, 2014	-124,820	-124,820
Common stock payable	858,000	858,000
Additional paid-in capital	42,930,750	43,529,923
Accumulated deficit	-46,701,284	-46,030,685
TOTAL STOCKHOLDERS' DEFICIT	-1,151,636	-965,905
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$1,447,508	$1,501,328

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Aug. 31, 2014	31-May-14
Consolidated Balance Sheets Parenthetical	'	'
Patents, net of accumulated amortization	$6,105	$3,605
License, net of accumulated amortization	111,758	60,898
Convertible notes payable net of unamortized discounts	$742,235	$674,886
STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Preferred stock series A, par value	$0.00	$0.00
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	4,000,000,000	4,000,000,000
Common Stock, shares issued	1,885,668,882	801,626,781
Common Stock, shares outstanding	1,760,869,080	676,806,979
Treasury Stock, Shares	124,819,820	124,819,820

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (Unaudited) (USD $)	3 Months Ended
	Aug. 31, 2014	Aug. 31, 2013
Consolidated Statements Of Operations	'	'
Sales	'	'
Cost of sales	'	'
Gross profit	'	'
Operating expenses:	'	'
General and administrative	250,772	259,443
Stock-based compensation - consultants	14,521	453,825
Depreciation expense	53,360	360
Total operating expenses	318,653	713,628
Loss from operations	-318,653	-713,628
Other income (expense):	'	'
Revaluation of derivative liability for convertible notes	-192,890	14,976
Interest expense	-147,433	-64,958
Total other income (expense)	-340,323	-49,982
Net loss	-658,976	-763,610
Net loss	-658,976	-763,610
Foreign Currency Adjustment	-11,650	'
Total Comprehensive Loss	($670,626)	($763,610)
Net loss per common share, basic and diluted	$0	($0.01)
Weighted average common shares outstanding	1,077,885,876	64,522,176

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Aug. 31, 2014	Aug. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net Loss	($658,976)	($763,610)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	53,360	360
Common stock issued as compensation	55,350	453,825
Non cash interest expense	123,955	64,958
Loss (gain) on derivative valuation	192,890	-14,976
Changes in Operating assets and liabilities:	'	'
Prepaid expenses	'	1
Accounts payable and accrued expenses	-4,801	-10,509
Accounts payable -related party	-21,366	'
Net cash used in operating activities	-226,178	-259,951
CASH FLOWS FROM INVESTING ACTIVITIES	'	'
Cash paid for investments	'	-127,902
Cash paid for loan receivable from consultant	'	-36,203
Net cash used in investing activities	'	-164,105
Total Comprehensive Loss	-11,650	'
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from convertible notes payable	128,448	282,500
Proceeds from loans payable to consultants and stockholders	108,885	155,199
Net cash provided by financing activities	237,333	437,699
Net increase(decrease) in cash and cash equivalents	-495	13,643
CASH BALANCE BEGINNING OF PERIOD	460	20
CASH BALANCE/(BANK OVERDRAFT) END OF PERIOD	-35	13,663
Cash paid for interest	20,424	'
Cash paid for taxes	'	'
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Shares issued for settlement of loans payable to consultants and stockholders	55,623	'
Shares issued for settlement of convertible notes payable	237,940	147,941
Shares issued for patent acquisition	'	35,500
Shares issued for equity interest in Imagic Ltd	'	$697,500

Description_of_Business

Description of Business	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 1 - Description of Business	'
	DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.
	On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification (“ASC”) Topic Nos, 860-20-25 and 860-20-40 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold.
	On February 29, 2012, the Company formed a new wholly owned subsidiary, Solarwerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solarwerks' current focus is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solarwerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ). Solarwerks, Inc. is currently in default with the Nevada Secretary of State.
	On June 20, 2012, the Company formed a new wholly-owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State.
	On July 20, 2012, the Company formed a new wholly-owned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.
	On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”). Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.
	On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.
	On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

Going_Concern

Going Concern	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 2 - Going Concern	'
	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors and the support of certain stockholders.
	These factors raise substantial doubt about the ability of the Company to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 3 - Basis of Presentation	'
	The unaudited consolidated financial statements as of August 31, 2014 and for the three months ended August 31, 2013 have been prepared in accordance with accounting principles generally accepted in the United States for interim consolidated financial information and with instructions to Form 10-Q. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the consolidated financial position as of August 31, 2014 and the results of operations and cash flows for the three months ended August 31, 2014 and 2013. The financial data and other information disclosed in these notes to the interim consolidated financial statements related to these periods are unaudited. The results for the three month period August 31, 2014 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending May 31, 2015. The consolidated balance sheet at May 31, 2014 has been derived from the audited consolidated financial statements at that date.
	Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended May 31, 2014 as included in our annual report on Form 10-K.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 4 - Summary of Significant Accounting Policies	'
	RECENT ACCOUNTNG PRONOUNCEMENTS
	In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 2014-10”). ASU 2014-10 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 2014-10, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended August 31, 2014 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
	PRINCIPLES OF CONSOLIDATION
	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3.
	Foreign Currency Translation and Transaction Gains and Losses
	We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of August 31, 2014 were $1.00 US to $.92 Canadian.
	USE OF ESTIMATES
	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various non-monetary transactions and the fair value of the derivative liability for convertible notes payable.
	CASH AND CASH EQUIVALENTS
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At August 31, 2014 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents, or amounts due bank, consisted only of cash overdraft in the bank.
	LOANS RECEIVABLE CONSULTANT
	The loan receivable consultants are a short term, less than one year note, due July 15, 2015, non-interest bearing
	NET LOSS PER COMMON SHARE
	Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.
	For the three months ended August 31, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Common Shares Equivalent
		Three Months Ended August 31,
		2014		2013
	Convertible notes payable		307,459,536		2,163,265
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		850,000
	Total common shares equivalent		358,309,536		53,013,265
	INTANGIBLE ASSETS
	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
	IMPAIRMENT OF LONG-LIVED ASSETS
	In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	STOCK-BASED COMPENSATION
	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
	RESEARCH AND DEVELOPMENT
	All research and development expenditures are expensed as incurred.
	REVENUE RECOGNITION
	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Investments

Investments	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 5 - Investments	'
	Investments consist of:
		August 31,		May 31,
		2014		2014
	Imagic Ltd. - 40% equity interest	$	1,094,166	$	1,094,166
	Barefoot Science Products & Services Inc. - 15% equity interest		50,000		50,000
	Total	$	1,144,166	$	1,144,166
	The cost of the 40% equity interest in Imagic Ltd. at August 31, 2014 consists of:
	July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	$	697,500
	December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.		96,005
	Cash payments to or for the benefit of Imagic Ltd.		150,661
	Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings		150,000
	Total	$	1,094,166
	Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the period ended August 31, 2014.

Licensing_Agreement_With_Wazza

Licensing Agreement With Wazzamba Sa	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 6 - Licensing Agreement With Wazzamba Sa	'
	During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the “Licensor”). The agreement provides the Company an exclusive license to use certain technology (which permits third-party subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor “Flat Fee” compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus “Revenue Share” compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party.
	At August 31, 2014, the Company has a recorded intangible asset for “Licensing Agreement with Wazzamba SA” in the amount of $300,000, and included the liability under the Licenses net of accumulated amortization. Commencing March 1, 2014, the Company will amortize the $300,000 intangible asset on a straight line basis over the remaining 17 months of the Initial Term ending July 31, 2015 (approximately $17,647 per month).
	On March 27, 2014, the Company paid $25,000 of the first $100,000 “Flat Fee” installment due the Licensor under the agreement. The other $75,000 due is presently past due.
	Licenses, net of accumulated amortization are as follows:
		August 31,			May 31,
		2014			2014
	Wazzamba, S.A .	$	300,000		$	300,000
	Bioharmonics		10,000			10,000
	Subtotal		310,000			310,000
	Accumulated amortization		(111,758	)		(60,898	)
	Total	$	198,242		$	249,102

Note_Payable_To_Bank

Note Payable To Bank	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 7 - Note Payable To Bank	'
	In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $180,000 bears interest at a rate at 10% payable monthly, and is due in full on December 31, 2014, and is secured by a 25,000,000 shares of Domark International, Inc ( Common Stock Reserve as defined in the Loan Agreement), a Guaranty of Payment from the Company’s chief financial officer and his wife, and certain real property owned by the Company’s chief financial officer and his wife.

Loans_Payable_to_Consultants_a

Loans Payable to Consultants and Stockholders	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 8 - Loans Payable to Consultants and Stockholders	'
	Loans payable to consultants and stockholders consist of:
		August 31,		May 31,
		2014		2014
	Consultant and stockholder	$	80,068	$	90,402
	President of DoMark		47,368		47,500
	Non - Exec Chairman of Domark		-		11,875
	Chairman of Barefoot Science and affiliate		21,500		21,500
	Consultant		16,097		16,097
	Consultant		2,603		1,598
	Total	$	167,636	$	188,972
	The loans are informal and do not provide for interest or a stated maturity date.

Convertible_Notes_Payable

Convertible Notes Payable	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 9 - Convertible Notes Payable	'
	At August 31, 2014, the convertible notes payable consisted of
	Date of Note		Noteholder	Interest Rate			Maturity Date	Principal Amount			Unamortized Debt Discount		Net Carrying Amount
	12/9/13		JMJ Financial Inc.		10	%	12/9/14		50,000	(i)		46,585		3,415
	2/13/14		JMJ Financial Inc.		10	%	8/13/14		10,364	(i)		10,364		0
	2/19/14		Iconic Holdings, LLC		10	%	9/19/14		30,000	(a)		29,065		935
	2/26/14		LG Capital, Inc.		8	%	9/26/14		25,475	(a)		25,475		0
	3/7/14		JSJ Investments, Inc		12	%	10/7/14		30,000	(g)		27,278		2,722
	3/28/14		Redwood Fund, III		10	%	9/28/14		50,000	(f)		48,757		1,243
	3/28/14		Redwood Management		10	%	9/28/14		50,000	(g)		48,757		1,243
	3/28/14		Asher Enterprises, Inc		8	%	9/28/14		42,500	(l)		34,060		8,440
	4/14/14		WHC Capital, Inc		12	%	10/14/14		53,000	(i)		51,716		1,284
	4/11/14		Tonaquint Inc		12	%	10/11/14		47,000	(g)		45,797		1,203
	4/24/14		JSJ Investments, Inc				10/24/14		50,000	(g)		48,757		1,243
	5/12/14		Iconic Holdings, LLC.		10	%	11/12/14		55,000	(g)		54,625		375
	5/14/14		KGM Worldwide, Inc		8	%	11/14/14		32,500	(l)		32,187		313
	6/12/14		Adar Bays, LLC.		8	%	12/12/15		52,500	(g)		52,363		137
	6/23/14		JMJ Financial, Inc.		10	%	12/23/14		50,000	(i)		49,864		136
	7/3/14		LG Capital, Inc		8	%	1/3/15		36,750	(a)		36,622		128
	7/22/14		Redwood Fund, III		10	%	1/22/15		100,082	(f)		99,963		119
	Totals							$	765,171		$	742,235	$	22,936
	Legend
	(a)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
	(b)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
	(c)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
	(d)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.
	(e)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(f)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.
	(g)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.
	(h)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(i)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.
	(j)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.
	(k)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(l)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

Stockholders_Equity

Stockholders Equity	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 10 - Stockholders Equity	'
	Series A Convertible Preferred Stock
	Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock.
	Common Stock Issuances
	On May 14, 2014, the Company reversed 15,483,636 shares of common stock for JSJ Investments, Inc. in cancellation of $8,516 principal amount of convertible notes payable.
	On June 3, 2014, the Company issued 19,408,888 shares of common stock for JSJ Investments, Inc. in satisfaction of $8,734 principal amount of convertible notes payable.
	On June 4, 2014, the Company issued 8,111,111 shares of common stock for Asher Enterprises, Inc. in satisfaction of $7,300 of principal amount of convertible notes payable.
	On June 11, 2014, the Company issued 14,423,077 shares of common stock for Gel Properties, Inc. in satisfaction of $7,500 of principal amount of convertible notes payable.
	On June 20, 2014, the Company issued 11,363,636 shares of common stock for Gel Properties, Inc. in satisfaction of $5,000 of principal amount of convertible noted payable.
	On June 22, 2014, the Company issued 20,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $14,400 of principal amount of convertible notes payable.
	On June 25, 2014, the Company issued 13,200,479 shares of common stock (valued at $14,521) in connection with consulting services rendered for Meadow Grove, LTD.
	On June 26, 2014, the Company issued 12,500,000 shares of common stock for Gel Properties, Inc. in satisfaction of $17,500 of principal amount of convertible notes payable.
	On June 30, 2014, the Company issued 66,920,560 shares of common stock for Iconic Holdings, LLC. in satisfaction of $16,730 of principal amount of convertible notes payable.
	On June 30, 2014, the Company issued 12,750,000 shares of common stock to Gel Properties, Inc. in satisfaction of $5,100 of principal amount of convertible noted payable.
	On July 2, 2014, the Company issued 28,771,780 shares of common stock to LG Capital, Inc. in satisfaction of $11,509 principal amount of convertible notes payable.
	On July 10, 2014, the Company issued 28,571,429 shares of common stock to Gel Properties, Inc.in satisfaction of $8,000 principal amount of convertible notes payable..
	On July 14, 2014, the Company issued 34,090,909 shares of common stock to Asher Enterprises, Inc. in satisfaction of $ 15,000 principal amount of convertible notes payable.
	On July 14, 2014, the Company issued 31,807,632 shares of common stock to LG Capital, Inc. in satisfaction of $8,906 principal amount of convertible notes payable.
	On July 14, 2014, the Company issued 42,857,143 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,000 principal amount of principal amount of convertible notes payable.
	On July 18, 2014, the Company issued 26,660,687 shares of common stock to Gel Properties, Inc. in satisfaction of $4,400 principal amount of convertible notes payable.
	On July 17, 2014, the Company issued 31,034,483 shares of common stock to Asher Enterprises, Inc. in satisfaction of $9,000 principal amount of convertible notes payable.
	On July 25, 2014, the Company issued 32,832,191 shares of common stock to LG Capital, Inc. in satisfaction of $5,253 principal amount of convertible notes payable.
	On July 31, 2014 the Company issued 52,630,136 shares of common stock to LG Capital, Inc in satisfaction of $8,000 principal amount of convertible notes payable..
	On July 31, 2014, the Company issued 41,000,000 shares of common stock to JMJ Financial, Inc. in satisfaction of $38,084 principal amount of convertible notes payable.
	On August 4, 2014, the Company issued 59,358,732 shares of common stock to LG Capital, Inc. in satisfaction of $9,497 principal amount of convertible notes payable.
	On August 6, 2014, the Company issued 56,659,863 shares of common stock to LG Capital, Inc in satisfaction of $9,065 principal amount of convertible noted payable.
	On August 7, 2014,, the Company issued 57,000,000 shares of common stock to JMJ Financial, Inc. in satisfaction of $13,680 principal amount of convertible notes payable.
	On August 13, 2014, the Company issued 140,000,000 shares of common stock to Davis in satisfaction of $41,102 principal amount of loan payable.
	On August 14, 2014 the Company issued 57,692,308 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,000 principal amount of convertible notes payable.
	On August 16, 2014, the Company issued 59,130,435 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,374 principal amount of convertible notes payable.
	On August 18, 2014, the Company issued 78,000,000 shares of common stock to JMJ Financial, Inc. in satisfaction of $14,040 principal amount of convertible notes payable.
	On August 29, 2014, the Company issued 62,753,278 shares of common stock to LG Capital, Inc. in satisfaction of $4,706 principal amount of convertible notes payable.
	Warrants to Purchase Common Stock
	A summary of warrant activity for the three months ended August 31, 2014 and for the year ended May 31, 2014 are as follows:
		Number of Warrants		Weighted Average Exercise Price
	Outstanding at May 31, 2012		-	$	-
	Granted		850,000		0.42
	Exercised		-		-
	Cancelled		-		-
	Outstanding at May 31, 2013		850,000		0.42
	Granted		-		-
	Exercised		-		-
	Cancelled		-		-
	Outstanding at August 31, 2014		850,000	$	0.42
	Warrants outstanding at August 31, 2014 consist of:
	Date Granted	Number Outstanding		Exercise price		Expiration Date
	25-May-12		100,000	$	1	25-May-15
	12-Jun-12		150,000	$	1	12-Jun-15
	26-Jun-12		100,000	$	1	26-Jun-15
	1-Jan-12		500,000	$	0.01	1-Jan-15
	Totals		850,000

Fair_Value_Measurements_and_De

Fair Value Measurements and Derivative Liabiliity	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 11 - Fair Value Measurements and Derivative Liabiliity	'
	The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based derivative financial instruments, the Companyuses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
	Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
	During the period ended August 31,, 2014 the Company entered into several convertible note agreements. The conversion option and the outstanding common stock warrants on that date which were tainted by the convertible note were classified as derivative liabilities at their fair value on the date of issuance.
	Under ASC-815 the conversion options embedded in the notes payable described in Note 9 require liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement.
	As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
	The three levels of the fair value hierarchy are as follows:
	Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
	Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.
	Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
	Derivative liability — the Company’s derivative liability is classified within Level 3 of the fair value hierarchy.
	The Company uses the Black Scholes Option Pricing Model to value its option based derivatives based upon the following assumptions: dividend yield of -0-%, volatility of stock price 0%, risk free rate varying from 8 to 12 % and an expected term equal to the remaining conversion of the note.
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as at August 31, 2014.
	Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
	LIABILITIES:
	Derivative liability- August 31, 2014		-		-		1,941,872		1,941,872
	Derivative liability- May 31, 2014		-		-		1,748,982		1,748,982

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
Note 12 - Commitments and Contingencies	'
	License Agreements
	On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018.
	On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. (“Bioharmoniecs”). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.
	In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 6.
	Employment Agreements
	On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 USD and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler.
	On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 USD and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.
	Lease Agreement
	On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At August 31, 2014, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:
	2015	$	33,793
	2016		47,616
	2017		47,616
	2018		47,616
	Thereafter		7,936
	Total	$	184,576

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Aug. 31, 2014
Summary Of Significant Accounting Policies Policies	'
Recent Accountng Pronouncements	'
	In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 2014-10”). ASU 2014-10 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 2014-10, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended August 31, 2014 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
Principles of Consolidation	'
	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3.
Foreign Currency Translation and Transaction Gains and Losses	'
	We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of August 31, 2014 were $1.00 US to $.92 Canadian.
Use of Estimates	'
	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various non-monetary transactions and the fair value of the derivative liability for convertible notes payable.
Cash and Cash Equivalents	'
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At August 31, 2014 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents, or amounts due bank, consisted only of cash overdraft in the bank.
Loans Receivable Consultant	'
	The loan receivable consultants are a short term, less than one year note, due July 15, 2015, non-interest bearing
Net Loss Per Common Share	'
	Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.
	For the three months ended August 31, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Common Shares Equivalent
		Three Months Ended August 31,
		2014		2013
	Convertible notes payable		307,459,536		2,163,265
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		850,000
	Total common shares equivalent		358,309,536		53,013,265
Intangible Assets	'
	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
Impairment of Long-Lived Assets	'
	In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Stock Based Compensation	'
	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
Research and Development	'
	All research and development expenditures are expensed as incurred.
Revenue Recognition	'
	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Aug. 31, 2014
Summary Of Significant Accounting Policies Tables	'
Net Loss Per Common Share	'
	For the three months ended August 31, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Common Shares Equivalent
		Three Months Ended August 31,
		2014		2013
	Convertible notes payable		307,459,536		2,163,265
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		850,000
	Total common shares equivalent		358,309,536		53,013,265

Investments_Tables

Investments (Tables)	3 Months Ended
	Aug. 31, 2014
Investments Tables	'
Investments	'
	Investments consist of:
		August 31,		May 31,
		2014		2014
	Imagic Ltd. - 40% equity interest	$	1,094,166	$	1,094,166
	Barefoot Science Products & Services Inc. - 15% equity interest		50,000		50,000
	Total	$	1,144,166	$	1,144,166
Cost of equity interest	'
	The cost of the 40% equity interest in Imagic Ltd. at August 31, 2014 consists of:
	July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	$	697,500
	December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.		96,005
	Cash payments to or for the benefit of Imagic Ltd.		150,661
	Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings		150,000
	Total	$	1,094,166

Licensing_Agreement_With_Wazza1

Licensing Agreement With Wazzamba Sa (Tables)	3 Months Ended
	Aug. 31, 2014
Licensing Agreement With Wazzamba Sa Tables	'
Licenses, net of accumulated amortization	'
	Licenses, net of accumulated amortization are as follows:
		August 31,			May 31,
		2014			2014
	Wazzamba, S.A .	$	300,000		$	300,000
	Bioharmonics		10,000			10,000
	Subtotal		310,000			310,000
	Accumulated amortization		(111,758	)		(60,898	)
	Total	$	198,242		$	249,102

Loans_Payable_to_Consultants_a1

Loans Payable to Consultants and Stockholders (Tables)	3 Months Ended
	Aug. 31, 2014
Loans Payable To Consultants And Stockholders Tables	'
Loans payable to consultants and stockholders	'
	Loans payable to consultants and stockholders consist of:
		August 31,		May 31,
		2014		2014
	Consultant and stockholder	$	80,068	$	90,402
	President of DoMark		47,368		47,500
	Non - Exec Chairman of Domark		-		11,875
	Chairman of Barefoot Science and affiliate		21,500		21,500
	Consultant		16,097		16,097
	Consultant		2,603		1,598
	Total	$	167,636	$	188,972

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Aug. 31, 2014
Convertible Notes Payable Tables	'
Convertible notes payable	'
	At August 31, 2014, the convertible notes payable consisted of
	Date of Note	Noteholder	Interest Rate			Maturity Date	Principal Amount			Unamortized Debt Discount		Net Carrying Amount
	12/9/13	JMJ Financial Inc.		10	%	12/9/14		50,000	(i)		46,585		3,415
	2/13/14	JMJ Financial Inc.		10	%	8/13/14		10,364	(i)		10,364		0
	2/19/14	Iconic Holdings, LLC		10	%	9/19/14		30,000	(a)		29,065		935
	2/26/14	LG Capital, Inc.		8	%	9/26/14		25,475	(a)		25,475		0
	3/7/14	JSJ Investments, Inc		12	%	10/7/14		30,000	(g)		27,278		2,722
	3/28/14	Redwood Fund, III		10	%	9/28/14		50,000	(f)		48,757		1,243
	3/28/14	Redwood Management		10	%	9/28/14		50,000	(g)		48,757		1,243
	3/28/14	Asher Enterprises, Inc		8	%	9/28/14		42,500	(l)		34,060		8,440
	4/14/14	WHC Capital, Inc		12	%	10/14/14		53,000	(i)		51,716		1,284
	4/11/14	Tonaquint Inc		12	%	10/11/14		47,000	(g)		45,797		1,203
	4/24/14	JSJ Investments, Inc				10/24/14		50,000	(g)		48,757		1,243
	5/12/14	Iconic Holdings, LLC.		10	%	11/12/14		55,000	(g)		54,625		375
	5/14/14	KGM Worldwide, Inc		8	%	11/14/14		32,500	(l)		32,187		313
	6/12/14	Adar Bays, LLC.		8	%	12/12/15		52,500	(g)		52,363		137
	6/23/14	JMJ Financial, Inc.		10	%	12/23/14		50,000	(i)		49,864		136
	7/3/14	LG Capital, Inc		8	%	1/3/15		36,750	(a)		36,622		128
	7/22/14	Redwood Fund, III		10	%	1/22/15		100,082	(f)		99,963		119
	Totals						$	765,171		$	742,235	$	22,936

Stockholders_Equity_Tables

Stockholders Equity (Tables)	3 Months Ended
	Aug. 31, 2014
Stockholders Equity Tables	'
Summary of warrant activity	'
	A summary of warrant activity for the three months ended August 31, 2014 and for the year ended May 31, 2014 are as follows:
		Number of Warrants		Weighted Average Exercise Price
	Outstanding at May 31, 2012		-	$	-
	Granted		850,000		0.42
	Exercised		-		-
	Cancelled		-		-
	Outstanding at May 31, 2013		850,000		0.42
	Granted		-		-
	Exercised		-		-
	Cancelled		-		-
	Outstanding at August 31, 2014		850,000	$	0.42
Warrants outstanding	'
	Warrants outstanding at August 31, 2014 consist of:
	Date Granted	Number Outstanding		Exercise price		Expiration Date
	25-May-12		100,000	$	1	25-May-15
	12-Jun-12		150,000	$	1	12-Jun-15
	26-Jun-12		100,000	$	1	26-Jun-15
	1-Jan-12		500,000	$	0.01	1-Jan-15
	Totals		850,000

Fair_Value_Measurements_and_De1

Fair Value Measurements and Derivative Liabiliity (Tables)	3 Months Ended
	Aug. 31, 2014
Fair Value Measurements And Derivative Liabiliity Tables	'
Recurring Fair Value Measurements	'
	The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as at August 31, 2014.
	Recurring Fair Value Measurements	Level 1		Level 2		Level 3		Total
	LIABILITIES:
	Derivative liability- August 31, 2014		-		-		1,941,872		1,941,872
	Derivative liability- May 31, 2014		-		-		1,748,982		1,748,982

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	3 Months Ended
	Aug. 31, 2014
Commitments And Contingencies Tables	'
Future Lease Commitments	'
	On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At August 31, 2014, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:
	2015	$	33,793
	2016		47,616
	2017		47,616
	2018		47,616
	Thereafter		7,936
	Total	$	184,576

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	3 Months Ended	12 Months Ended
	Aug. 31, 2014	31-May-14
Summary Of Significant Accounting Policies Details	'	'
Convertible notes payable	307,459,536	2,163,265
Series A convertible preferred stock	50,000,000	50,000,000
Warrants	850,000	850,000
Total common shares equivalent	358,309,536	53,013,265

Investments_Details

Investments (Details) (USD $)	Aug. 31, 2014	31-May-14
Investments Details	'	'
Imagic Ltd. - 40% equity interest	$1,094,166	$1,094,166
Barefoot Science Products & Services Inc. - 15% equity interest	50,000	50,000
Total	$1,144,166	$1,144,166

Investments_Details_1

Investments (Details 1) (USD $)	Aug. 31, 2014	31-May-14
Investments Details	'	'
July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.	697,500	'
December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.	96,005	'
Cash payments to or for the benefit of Imagic Ltd.	$150,661	'
Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings	150,000	'
Total	$1,094,166	$1,094,166

Licensing_Agreement_With_Wazza2

Licensing Agreement With Wazzamba Sa (Details) (USD $)	Aug. 31, 2014	31-May-14
Licensing Agreement With Wazzamba Sa Details	'	'
Wazzamba, S.A.	$300,000	$300,000
Bioharmonics	10,000	10,000
Subtotal	310,000	310,000
Accumulated amortization	-111,758	-60,898
Total	$198,242	$249,102

Loans_Payable_to_Consultants_a2

Loans Payable to Consultants and Stockholders (Details) (USD $)	Aug. 31, 2014	31-May-14
Loans payable to consultants and stockholders	$167,636	$188,972
Consultant And Stockholder [Member]	'	'
Loans payable to consultants and stockholders	80,068	90,402
President Of DoMark [Member]	'	'
Loans payable to consultants and stockholders	47,368	47,500
Non Exec Chairman Of Domark [Member]	'	'
Loans payable to consultants and stockholders	'	11,875
Chairman Of Barefoot Science And Affiliate [Member]	'	'
Loans payable to consultants and stockholders	21,500	21,500
Consultant [Member]	'	'
Loans payable to consultants and stockholders	16,097	16,097
Consultant One [Member]	'	'
Loans payable to consultants and stockholders	$2,603	$1,598

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)

Aug. 31, 2014

31-May-14

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

Aug. 31, 2014

JMJ Financial Inc. [Member]

JMJ Financial Inc One [Member]

Iconic Holdings, LLC [Member]

LG Capital [Member]

JSJ Investments Inc. [Member]

Redwood Fund III [Member]

Redwood Mgt LLC [Member]

Asher Enterprises Inc. [Member]

WHC Capital [Member]

Tonaquint [Member]

JSJ Investments Inc. One [Member]

Iconic Holdings, LLC One [Member]

KGM Worldwide, Inc [Member]

Adar Bays, LLC. [Member]

JMJ Financial Inc Two [Member]

LG Capital One [Member]

Redwood Fund III One [Member]

Date of Note

'

'

9-Dec-13

13-Feb-14

19-Feb-14

26-Feb-14

7-Mar-14

28-Mar-14

28-Mar-14

28-Mar-14

14-Apr-14

11-Apr-14

24-Apr-14

12-May-14

14-May-14

12-Jun-14

23-Jun-14

3-Jul-14

22-Jul-14

Interest Rate

'

'

10.00%

10.00%

10.00%

8.00%

12.00%

10.00%

10.00%

8.00%

12.00%

12.00%

0.00%

10.00%

8.00%

8.00%

10.00%

8.00%

10.00%

Maturity date

'

'

9-Dec-14

13-Aug-14

19-Sep-14

26-Sep-14

7-Oct-14

28-Sep-14

28-Sep-14

28-Sep-14

14-Oct-14

11-Oct-14

24-Oct-14

12-Nov-14

14-Nov-14

12-Dec-15

23-Dec-14

3-Jan-15

22-Jan-15

Principal Amount

$765,171

'

$50,000

[1]

$10,364

[1]

$30,000

[2]

$25,475

[2]

$30,000

[3]

$50,000

[4]

$50,000

[3]

$42,500

[5]

$53,000

[1]

$47,000

[3]

$50,000

[3]

$55,000

[3]

$32,500

[5]

$52,500

[3]

$50,000

[1]

$36,750

[2]

$100,082

[4]

Unamortized Debt Discount

742,235

674,886

46,585

10,364

29,065

25,475

27,278

48,757

48,757

34,060

51,716

45,797

48,757

54,625

32,187

52,363

49,864

36,622

99,963

Net Carrying Amount

$22,936

$67,414

$3,415

$0

$935

$0

$2,722

$1,243

$1,243

$8,440

$1,284

$1,203

$1,243

$375

$313

$137

$136

$128

$119

[1]

(j) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.

[2]

(a) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.

[3]

(g) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.

[4]

(f) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.

[5]

(l) At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

Stockholders_Deficit_Details

Stockholders' Deficit (Details) (USD $)	3 Months Ended	12 Months Ended
	Aug. 31, 2014	31-May-14
Stockholders Deficit Details	'	'
Outstanding Number of Warrants, Beginning Balance	850,000	'
Granted	'	850,000
Exercised	'	'
Cancelled	'	'
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance	$0.42	'
Granted	'	$0.42
Exercised	'	'
Cancelled	'	'
Weighted Average Exercise Price, Ending Balance	$0.42	$0.42

Stockholders_Deficit_Details_1

Stockholders' Deficit (Details 1) (USD $)	Aug. 31, 2014	31-May-14	31-May-13	Aug. 31, 2014	Aug. 31, 2014	Aug. 31, 2014	Aug. 31, 2014
				Warrant [Member]	Warrant One [Member]	Warrant Two [Member]	Warrant Three [Member]
Date Granted	'	'	'	25-May-12	12-Jun-12	26-Jun-12	1-Jan-12
Number Of Warrant Outstanding	850,000	850,000	'	100,000	150,000	100,000	500,000
Exercise price	'	'	'	$1	$1	$1	$0.01
Expiration Date	'	'	'	25-May-15	12-Jun-15	26-Jun-15	1-Jan-15

Fair_Value_Measurements_and_De2

Fair Value Measurements and Derivative Liabiliity (Details) (USD $)	Aug. 31, 2014
LIABILITIES	'
Derivative liability- August 31, 2014	$1,941,872
Derivative liability- May 31, 2014	1,748,982
Level 1 [Member]	'
LIABILITIES	'
Derivative liability- August 31, 2014	'
Derivative liability- May 31, 2014	'
Level 2 [Member]	'
LIABILITIES	'
Derivative liability- August 31, 2014	'
Derivative liability- May 31, 2014	'
Level 3 [Member]	'
LIABILITIES	'
Derivative liability- August 31, 2014	1,941,872
Derivative liability- May 31, 2014	$1,748,982

Recovered_Sheet1

Commitments And Contingencies (Details) (USD $)	Aug. 31, 2014
Commitments And Contingencies Details	'
2015	$33,793
2016	47,616
2017	47,616
2018	47,616
Thereafter	7,936
Total	$184,576